Top 5 Drug Trends: Microdosing, GLP-1s, Cannabis Testing, ADHD Treatment, and Medical Spa Investments 9-4-24
In this episode, Scott Becker explores five emerging drug trends, including the rise of microdosing psychedelics for joint pain, expanded uses of GLP-1s, the complexities of cannabis testing, evolving approaches to adult ADHD treatment, and the booming medical spa industry driven by private equity investments.
The Evolution of Surgery Centers: Insights from Amber Walsh, Partner at McGuireWoods 9-4-24
In this episode, Amber Walsh, a seasoned expert in healthcare and private equity, provides a concise history of surgery centers, exploring their impact on hospitals, health systems, and the investment landscape. She also discusses current trends, challenges, and the role of private equity in shaping the future of surgery centers.
10 Business News Stories We Are Following Today 9-4-24
In today’s episode, Scott Becker covers ten key business stories, including the Nordstrom family’s move to take the company private, signs of economic slowdown with tumbling job openings, and major private equity deals like Blackstone’s $16 billion acquisition. Plus, insights into retail challenges for Lululemon, Dollar Tree, and more.
Navigating DOJ Investigations and Litigation Trends: Insights from David Pivnick 9-3-24
David Pivnick, Partner at McGuireWoods LLP, discusses the latest trends in DOJ investigations, the impact of whistleblower complaints, and the evolving landscape of private equity litigation. Gain expert insights on how the DOJ’s focus areas are shaping the legal environment for healthcare providers and private equity funds.
The News is All Bad Today – 14 Quick Notes 9-3-24
In this episode, Scott Becker delivers 14 rapid updates on a challenging day in the markets, highlighting significant declines in major stocks like NVIDIA and Boeing, concerns over slowing U.S. manufacturing, and the ongoing volatility in private equity.
Markets Tanking, Boeing & NVIDIA Falling + More 9-3-24
In today’s episode, Scott Becker covers the market downturn fueled by economic concerns, with oil prices hitting new lows and major companies like Boeing and Nvidia facing significant declines. Despite Nvidia’s drop, it remains a standout performer this year, and the impact of Medicare’s drug price negotiations is also highlighted.
14 Business News Stories We Are Following Today 9-3-24
In today’s episode, Scott Becker discusses the market’s downward trend after recent gains, Intel’s unexpected 9.5% surge amidst potential spin-offs, and the challenges facing Dollar General as retail giants like Walmart and Target dominate the lower-income market.
Navigating the Mortgage Industry with Brian Levy: Legal Insights and Market Trends 8-30-24
In this episode, Scott Becker interviews Brian Levy, Of Counsel at Katten & Temple, LLP, as he shares his extensive experience in the mortgage industry, discussing regulatory compliance, market trends, and the evolution of his practice. Levy also talks about his popular newsletter, “Mortgage Musings,” and offers a unique perspective on the future of the […]
Market Movers and Political Shifts: A Look at Disney, Tariffs, and Leadership Comebacks 8-30-24
In this episode, Scott Becker discusses Disney’s ongoing struggles, Kamala Harris’s stance on fracking, and Donald Trump’s tariff policies. Plus, insights on leadership comebacks at Salesforce and Starbucks, and a light-hearted take on impulse control in golf.
Market Trends + Winners and Losers in Retail: 11 Stories We Are Following Today 8-30-24
This episode of the Becker Private Equity and Business Podcast covers the latest market movements, highlighting significant gains and losses in retail giants like Dollar General, Dollar Tree, and Birkenstock.